T2 Biosystems Inc. (TTOO)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
11 Apr 2022 |
SPERZEL JOHN J III |
Chairman, CEO, and President |
07 Apr 2022 |
30,000 |
0.50 |
15,000 |
11 Apr 2022 |
BARCLAY ALEC |
Chief Operations Officer |
08 Apr 2022 |
12,952 |
0.50 |
6,476 |
11 Apr 2022 |
GIBBS MICHAEL TERRENCE |
General Counsel |
07 Apr 2022 |
10,000 |
0.49 |
4,900 |
11 Apr 2022 |
SPRAGUE JOHN M |
Chief Financial Officer |
08 Apr 2022 |
10,000 |
0.48 |
4,767 |
11 Apr 2022 |
GIFFIN BRETT A. |
Chief Commercial Officer |
08 Apr 2022 |
10,600 |
0.49 |
5,183 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock